Back to VA Vanguard Capital Management LLC

TVTX

2 quarters

Position history for VAVanguard Capital Management LLC's holdings in Travere Therapeutics, Inc.

Yes. Vanguard Capital Management holds 4,108,694 shares of TVTX (Travere Therapeutics), worth $233.4M, as of its Q2 2026 13F filing. It increased the position by 62,882 shares (+1.6%) from Q1 2026. Vanguard Capital Management has held TVTX in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$233.4M

Current Shares

4.1M

Total Value Change

+$113.2M

Total Shares Change

+62,882

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.1M
+1.6%
$233.4M0.0%$56.81
31
2026-Q1
First report
4M
-
$120.2M0.0%$29.71
0

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used